-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Amy Weaver
-
Stock symbol
-
CRM
-
Transactions as of
-
Mar 22, 2024
-
Transactions value $
-
-$819,600
-
Form type
-
4
-
Date filed
-
3/22/2024, 08:03 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CRM |
Common Stock |
Options Exercise |
$405K |
+2.63K |
+6.83% |
$154.14 |
41.1K |
Mar 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Options Exercise |
$473K |
+2.2K |
+5.35% |
$215.17 |
43.3K |
Mar 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Options Exercise |
$491K |
+2.25K |
+5.19% |
$218.21 |
45.6K |
Mar 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Sale |
-$2.19M |
-7.08K |
-15.53% |
$309.32 |
38.5K |
Mar 22, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.63K |
-49.99% |
$0.00 |
2.63K |
Mar 22, 2024 |
Common Stock |
2.63K |
$154.14 |
Direct |
F1, F2 |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.2K |
-7.7% |
$0.00 |
26.4K |
Mar 22, 2024 |
Common Stock |
2.2K |
$215.17 |
Direct |
F1, F3 |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.25K |
-4% |
$0.00 |
54K |
Mar 22, 2024 |
Common Stock |
2.25K |
$218.21 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: